13F-HR filed by Venrock Adviser, LLC
Venrock Adviser, LLC filed this 13F-HR for the quarter ended 2025-06-30, filed 2025-08-14, with 31 holding rows worth $1,334,436,576.
- Accession
- 0001415889-25-021914
- Filer
- CIK 1615982
- Filed
- 2025-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2025
A holdings report, 31 entries on the cover page, a total value of $1,334,436,576 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,334,436,576 with VALUE read as dollars as filed, 13F file number 028-20281. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 8,493,321 | $368,864,931 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 12,762,462 | $118,435,647 | dollars as filed | |
| METSERA INC | 59267L107 | COM | 3,750,662 | $106,706,334 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 4,026,331 | $80,768,200 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 6,728,985 | $76,071,175 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 6,596,885 | $66,958,383 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 3,882,709 | $54,280,272 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 4,148,428 | $46,503,878 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 2,685,448 | $40,201,157 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 2,047,620 | $36,038,112 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 4,755,411 | $34,143,851 | dollars as filed | |
| JADE BIOSCIENCES INC | 008064206 | COM NEW | 3,220,364 | $32,171,436 | dollars as filed | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 13,969,882 | $31,711,632 | dollars as filed | |
| CIDARA THERAPEUTICS INC | 171757206 | COM NEW | 639,088 | $31,129,976 | dollars as filed | |
| UPSTREAM BIO INC | 91678A107 | COMMON STOCK | 2,295,319 | $25,202,603 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 17,857,083 | $22,678,495 | dollars as filed | |
| CRESCENT BIOPHARMA INC | G2545C104 | COMMON STOCK | 1,387,864 | $22,400,125 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 2,173,913 | $20,695,652 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 8,884,263 | $20,256,120 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 1,000,000 | $18,630,000 | dollars as filed | |
| ENGENE HOLDINGS INC | 29286M105 | COM | 5,046,414 | $18,368,947 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 2,457,348 | $13,171,385 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 1,379,965 | $10,391,136 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 1,345,780 | $10,295,217 | dollars as filed | |
| PERCEPTIVE CAPITAL SOLUTIONS | G70077105 | CL A ORD SHS | 750,000 | $7,965,000 | dollars as filed | |
| SEPTERNA INC COM | 81734D104 | Stock | 540,453 | $5,712,588 | dollars as filed | |
| SURROZEN INC | 86889P208 | COMMON STOCK | 632,931 | $5,658,403 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 4,631,216 | $4,862,777 | dollars as filed | |
| ARTIVA BIOTHERAPEUTICS INC | 04317A107 | COM | 1,609,569 | $2,430,449 | dollars as filed | |
| CASI PHARMACEUTICALS INC COM NEW | G1933S101 | Stock | 987,259 | $1,164,966 | dollars as filed | |
| TENAX THERAPEUTICS INC | 88032L605 | COM NEW | 98,564 | $567,729 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001415889-25-021914 | this filing | 2025-08-14 | acceptance time not in the bulk data set |